Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

682 evidence items · page 18 / 28

20 subjectsGlobin analysis in 30 SCA subjects showed that 20 had four alpha-globin genes, eight had three, and two had two alpha-globin genes.

Nigeriadrépanocytosepublished 1989African journal of medicine and medical scienceseurope_pmcdocument of 6 observations

HbA2 was significantly elevated in HbSS individuals with two alpha gene deletions.

Nigeriaalpha thalassemia · drépanocytosepublished 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001

95.6 %Among 135 physicians caring for SCD patients in a southwestern state of Nigeria, 129 (95.6%) routinely recommend premarital SCD genetic counseling and testing.

Nigeriadrépanocytosepublished 2020TheScientificWorldJournalPubMeddocument of 9 observations

86 %86% of respondents supported newborn screening for sickle cell disease.

Nigeriadrépanocytosepublished 2018Cureuseurope_pmcdocument of 3 observations

A simplified hydroxyurea dosing strategy achieved high levels of treatment adherence in paediatric sickle cell anaemia patients in South East Nigeria.

Nigeriadrépanocytoseobserved 2022–2024published 2025BMC pediatricsPubMeddocument of 3 observations

88.9 %Anaemia was prevalent in 88.9% of sickle cell anaemia individuals.

Nigeriadrépanocytosepublished 2021African health sciencesPubMeddocument of 7 observations

4.5 %Hepatitis C infection was observed in 4.5% of the children.

Nigeriadrépanocytose · hépatite Cpublished 2021West African journal of medicinePubMeddocument of 10 observations

90 %90.0% of senior secondary school students in Surulere Local Government Area, Lagos, Nigeria were aware of sickle cell disease.

Nigeriadrépanocytosepublished 2022African journal of primary health care & family medicinePubMeddocument of 11 observations

0.009 p-valueA significantly higher proportion of the cases than the controls had T wave abnormality (p = 0.009).

Nigeriadrépanocytosepublished 2023Ghana medical journalPubMeddocument of 7 observations

26 samplesAn additional 26 samples from a separate sickle cell disease cohort were genotyped.

Nigeriadrépanocytosepublished 2026African journal of laboratory medicineeurope_pmcdocument of 5 observations

Catalase activity was higher in sickle cell anaemia individuals compared to controls.

Nigeriadrépanocytosepublished 2021African health sciencesPubMeddocument of 7 observations

50 %The histological pattern in the 22 patients who had renal biopsies showed mesangioproliferative glomerulonephritis in 11 (50%) patients.

Nigeriadrépanocytose · mesangioproliferative glomerulonephritispublished 2024The Nigerian postgraduate medical journalPubMeddocument of 10 observations

20 %20% of respondents relied on faith when making marital decisions affecting sickle cell disease birth risk.

Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 6 observations

17.6 %The prevalence of alloimmunization in patients with sickle cell disease was 17.6%.

Nigeriadrépanocytosepublished 2025Transfusion and apheresis science : official journal of the World Apheresis Association : europe_pmcdocument of 9 observations

Significantly higher copper levels were observed in sickle cell anaemia patients during vaso-occlusive crisis than in steady clinical state, with a p-value less than 0.001.

Nigeriadrépanocytosepublished 2019African health sciencesPubMeddocument of 6 observations

2.5 %Among 3622 enrolled sickle cell disease patients in Nigeria, 2.5% had experienced stroke.

NigeriaAVC · drépanocytosepublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

5.9 %The mean foetal haemoglobin (HbF) level in sickle cell anaemia patients in Nigeria was 5.9% with a standard deviation of 3.8%.

Nigeriadrépanocytosepublished 1990European journal of haematologyeurope_pmcdocument of 5 observations

97 %Two hundred and ninety (97%) of the caregivers expressed willingness to participate in the Newborn Screening for Sickle Cell Disease.

Nigeriadrépanocytosepublished 2024Frontiers in public healtheurope_pmcdocument of 8 observations

3.35 odds_ratioIn multivariate analysis, neuralgic pain was associated with painful crisis with an odds ratio of 3.35.

NigeriadrépanocytosePubMeddocument of 10 observations

180 ng/mlThe median serum ferritin level of children with sickle cell disease was 180.00 ng/ml with an interquartile range of 237.50 ng/ml.

Nigeriadrépanocytosepublished 2023West African journal of medicinePubMeddocument of 8 observations

0.351 correlation_coefficientHopelessness had a modest positive correlation with anxiety (r = 0.351, P < 0.001) among clinically stable Nigerian adults with sickle cell disease.

Nigeriadrépanocytosepublished 2020Nigerian journal of clinical practicePubMeddocument of 8 observations

2.5 %Nigeria has 2–3% of its population affected by sickle cell disease.

NigeriadrépanocytosePubMeddocument of 7 observations

42.3 %Left ventricular hypertrophy was observed in 42.3% of pediatric sickle cell anaemia patients with severe anaemia.

Nigeriadrépanocytoseobserved 2023published 2025BMC pediatricsPubMeddocument of 16 observations

6.3 %Among 3622 enrolled sickle cell disease patients in Nigeria, 6.3% had renal complications.

Nigeriadrépanocytose · renal complicationspublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

31.8 %The incidence of bacterial infection in hospitalized children with sickle cell anaemia was 31.8%.

Nigeriadrépanocytosepublished 2021The Nigerian postgraduate medical journalPubMeddocument of 8 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.